BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25444596)

  • 1. BDNF polymorphism associates with decline in set shifting in Parkinson's disease.
    van der Kolk NM; Speelman AD; van Nimwegen M; Kessels RP; IntHout J; Hakobjan M; Munneke M; Bloem BR; van de Warrenburg BP
    Neurobiol Aging; 2015 Mar; 36(3):1605.e1-6. PubMed ID: 25444596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
    Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms.
    Cagni FC; Campêlo CLDC; Coimbra DG; Barbosa MR; Júnior LGO; Neto ABS; Ribeiro AM; Júnior COG; Gomes de Andrade T; Silva RH
    J Neuropsychiatry Clin Neurosci; 2017; 29(2):142-147. PubMed ID: 27852165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
    Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
    J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Behav Brain Res; 2019 Oct; 372():112039. PubMed ID: 31202861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
    Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
    Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
    Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
    Altmann V; Schumacher-Schuh AF; Rieck M; Callegari-Jacques SM; Rieder CR; Hutz MH
    Neurosci Lett; 2016 Feb; 615():88-91. PubMed ID: 26806863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
    Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease.
    Foltynie T; Lewis SG; Goldberg TE; Blackwell AD; Kolachana BS; Weinberger DR; Robbins TW; Barker RA
    J Neurol; 2005 Jul; 252(7):833-8. PubMed ID: 15772739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Lee YH; Song GG
    J Mot Behav; 2014; 46(1):59-66. PubMed ID: 24329127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.
    Hong CJ; Liu HC; Liu TY; Lin CH; Cheng CY; Tsai SJ
    Neurosci Lett; 2003 Dec; 353(1):75-7. PubMed ID: 14642442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
    Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
    Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common polymorphism in the brain-derived neurotrophic factor gene in patients with adult-onset primary focal and segmental dystonia.
    Svetel MV; Djuric G; Novakovic I; Dobricic V; Stefanova E; Kresojevic N; Tomic A; Jankovic M; Petrovic I; Pekmezovic T; Kostic VS
    Acta Neurol Belg; 2013 Sep; 113(3):243-5. PubMed ID: 23381842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of the Met allele of the brain-derived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage.
    Vilkki J; Lappalainen J; Juvela S; Kanarek K; Hernesniemi JA; Siironen J
    Neurosurgery; 2008 Aug; 63(2):198-203; discussion 203. PubMed ID: 18797348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to males.
    Bus BA; Arias-Vasquez A; Franke B; Prickaerts J; de Graaf J; Voshaar RC
    Neuropsychobiology; 2012 Jun; 65(4):183-7. PubMed ID: 22538247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.
    Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; R RS
    Rejuvenation Res; 2015 Feb; 18(1):40-7. PubMed ID: 25431370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease.
    Foltynie T; Cheeran B; Williams-Gray CH; Edwards MJ; Schneider SA; Weinberger D; Rothwell JC; Barker RA; Bhatia KP
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):141-4. PubMed ID: 18977816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.